GRAIL to Announce Second Quarter 2024 Financial Results
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company focused on early cancer detection, has announced it will release its second quarter 2024 financial results on Tuesday, August 13, 2024, after market close. The company will host a webcast and conference call at 1:30 p.m. PT / 4:30 p.m. ET on the same day to discuss the results and business progress.
Investors and interested parties can access the live webcast and recorded replay through the investor relations section of GRAIL's website at investors.grail.com. Registration for the teleconference is available at https://grail-q2-financial-results-2024.open-exchange.net/. Participants are advised to register and join the webcast at least ten minutes before the scheduled start time to ensure timely connection.
GRAIL, Inc. (Nasdaq: GRAL), un'azienda sanitaria focalizzata sulla rilevazione precoce del cancro, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 martedì 13 agosto 2024, dopo la chiusura del mercato. L'azienda organizzerà un webcast e una teleconferenza alle 13:30 PT / 16:30 ET dello stesso giorno per discutere dei risultati e dei progressi aziendali.
Investitori e parti interessate possono accedere al webcast in diretta e alla registrazione della riproduzione nella sezione delle relazioni con gli investitori del sito web di GRAIL all'indirizzo investors.grail.com. La registrazione per la teleconferenza è disponibile su https://grail-q2-financial-results-2024.open-exchange.net/. Si consiglia ai partecipanti di registrarsi e unirsi al webcast almeno dieci minuti prima dell'orario programmato per garantire una connessione tempestiva.
GRAIL, Inc. (Nasdaq: GRAL), una empresa de atención médica enfocada en la detección temprana del cáncer, ha anunciado que lanzará sus resultados financieros del segundo trimestre de 2024 el martes 13 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo un webcast y una llamada de conferencia a la 1:30 p.m. PT / 4:30 p.m. ET el mismo día para discutir los resultados y el progreso del negocio.
Los inversores y partes interesadas pueden acceder al webcast en vivo y a la grabación de reproducción a través de la sección de relaciones con inversores del sitio web de GRAIL en investors.grail.com. La inscripción para la teleconferencia está disponible en https://grail-q2-financial-results-2024.open-exchange.net/. Se aconseja a los participantes registrarse y unirse al webcast al menos diez minutos antes de la hora programada para garantizar una conexión oportuna.
GRAIL, Inc. (Nasdaq: GRAL), 초기 암 탐지에 중점을 둔 헬스케어 회사는 2024년 8월 13일 화요일, 시장 마감 후에 2024년 2분기 재무 결과를 발표할 것이라고 발표했습니다. 같은 날 오후 1시 30분 PT / 오후 4시 30분 ET에 웹캐스트와 컨퍼런스 콜을 진행하여 결과 및 비즈니스 진행 사항에 대해 논의할 예정입니다.
투자자 및 관심 있는 당사자는 GRAIL 웹사이트의 투자자 관계 섹션에서 라이브 웹캐스트 및 녹화 다시보기에 접근할 수 있습니다: investors.grail.com. 전화 회의 등록은 https://grail-q2-financial-results-2024.open-exchange.net/에서 가능합니다. 참석자들은 적시에 연결을 보장하기 위해 예정된 시작 시간 최소 10분 전에 웹캐스트에 등록하고 참여할 것을 권장합니다.
GRAIL, Inc. (Nasdaq: GRAL), une entreprise de soins de santé axée sur la détection précoce du cancer, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le mardi 13 août 2024, après la fermeture du marché. L'entreprise organisera un webinaire et une conférence téléphonique le même jour à 13h30 PT / 16h30 ET pour discuter des résultats et des progrès de l'entreprise.
Les investisseurs et les parties intéressées peuvent accéder au webinaire en direct et à l'enregistrement de la rediffusion via la section des relations avec les investisseurs du site web de GRAIL à l'adresse investors.grail.com. L'inscription pour la téléconférence est disponible sur https://grail-q2-financial-results-2024.open-exchange.net/. Les participants sont invités à s'inscrire et à rejoindre le webinaire au moins dix minutes avant l'heure de début prévue pour garantir une connexion en temps voulu.
GRAIL, Inc. (Nasdaq: GRAL), ein Gesundheitsunternehmen, das sich auf die frühe Krebsdetektion konzentriert, hat bekannt gegeben, dass es am Dienstag, den 13. August 2024, nach Marktschluss seine Finanzergebnisse für das zweite Quartal 2024 veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr PT / 16:30 Uhr ET einen Webcast und eine Telefonkonferenz veranstalten, um die Ergebnisse und den Geschäftsfortschritt zu erörtern.
Investoren und interessierte Parteien können über den Bereich für Investorenbeziehungen auf der GRAIL-Website investors.grail.com auf das Live-Webcast und die aufgezeichnete Wiederholung zugreifen. Die Anmeldung zur Telefonkonferenz ist unter https://grail-q2-financial-results-2024.open-exchange.net/ verfügbar. Den Teilnehmern wird empfohlen, sich mindestens zehn Minuten vor dem geplanten Startzeitpunkt anzumelden und dem Webcast beizutreten, um eine rechtzeitige Verbindung sicherzustellen.
- GRAIL is maintaining transparency by hosting a public webcast and conference call to discuss financial results
- The company provides easy access to financial information through its investor relations website
- None.
Second Quarter 2024 Webcast and Conference Call Details
A link to the live webcast and recorded replay will be available at the investor relations section of GRAIL's website at investors.grail.com.
Please register for the live event at https://grail-q2-financial-results-2024.open-exchange.net/.
To ensure timely connection, please register for the teleconference and join the webcast at least ten minutes before the scheduled start of the call. The live webcast and recorded replay are open to all interested parties.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-announce-second-quarter-2024-financial-results-302211341.html
SOURCE GRAIL, Inc.
FAQ
When will GRAIL (GRAL) release its Q2 2024 financial results?
What time is GRAIL's Q2 2024 earnings call scheduled for?
How can investors access GRAIL's Q2 2024 earnings webcast?
What is the registration link for GRAIL's Q2 2024 financial results teleconference?
